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Inflammatory cells, including macrophages and microglia, synthesize and release the oxysterol 25-hydroxycholesterol (25HC),
which has antiviral and immunomodulatory properties. Here, we examined the effects of lipopolysaccharide (LPS), an activator of innate immunity, on 25HC production in microglia, and the effects of LPS and 25HC on CA1 hippocampal synaptic
plasticity and learning. In primary microglia, LPS markedly increases the expression of cholesterol 25-hydroxylase (Ch25h),
the key enzyme involved in 25HC synthesis, and increases the levels of secreted 25HC. Wild-type microglia produced higher
levels of 25HC than Ch25h knock-out (KO) microglia with or without LPS. LPS treatment also disrupts long-term potentiation (LTP) in hippocampal slices via induction of a form of NMDA receptor-dependent metaplasticity. The inhibitory effects
of LPS on LTP were mimicked by exogenous 25HC, and were not observed in slices from Ch25h KO mice. In vivo, LPS treatment also disrupts LTP and inhibits one-trial learning in wild-type mice, but not Ch25h KO mice. These results demonstrate
that the oxysterol 25HC is a key modulator of synaptic plasticity and memory under proinflammatory stimuli.
Key words: lipopolysaccharide; long-term potentiation; memory; metaplasticity; neurosteroids; oxysterols
Significance Statement
Neuroinflammation is thought to contribute to cognitive impairment in multiple neuropsychiatric illnesses. In this study, we
found that a proinflammatory stimulus, LPS, disrupts hippocampal LTP via a metaplastic mechanism. The effects of LPS on
LTP are mimicked by the oxysterol 25-hydroxycholesterol (25HC), an immune mediator synthesized in brain microglia.
Effects of LPS on both synaptic plasticity and one-trial inhibitory avoidance learning are eliminated in mice deficient in
Ch25h (cholesterol 25-hydroxylase), the primary enzyme responsible for endogenous 25HC synthesis. Thus, these results indicate that 25HC is a key mediator of the effects of an inflammatory stimulus on hippocampal function and open new potential
avenues to overcome the effects of neuroinflammation on brain function.
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Neuroinflammation and microglial activation appear to contribute
to the pathophysiology of multiple neuropsychiatric disorders
including neurodegenerative illnesses such as Alzheimer’s disease
(Wang and Colonna, 2019) and possibly even psychiatric disorders,
including schizophrenia and major depression (Lathe et al., 2014;
Hodes et al., 2015; Yirmiya et al., 2015; Iwata et al., 2016). All of
these disorders are associated with significant cognitive impairment
that contributes to disability and illness burden (Wohleb et al.,
2016). Mechanisms underlying inflammation-associated cognitive
impairment include microglia-secreted factors that contribute to
synaptic dysfunction and impaired synaptic plasticity necessary for
learning and memory (Wu et al., 2015).
In peripheral macrophages, the cholesterol-derived oxysterol 25hydroxycholesterol (25HC), the predominant oxysterol produced
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and released from macrophages (Blanc et al., 2013), contributes to
inflammatory responses. Proinflammatory stimuli, including the
bacterial cell wall endotoxin lipopolysaccharide (LPS) and other
monocyte activators (Bauman et al., 2009; Gold et al., 2014; Luu et
al., 2016), promote the expression of cholesterol-25-hydroxylase
(Ch25h), the principal enzyme responsible for 25HC synthesis (Lund
et al., 1998). Similar changes in Ch25h and 25HC following inflammatory stimuli are seen in brain, raising the possibility that 25HC is
an important mediator of neuroinflammation, potentially impacting
neural circuits and behavior (Min et al., 2009; Waltl et al., 2013;
Simon, 2014; Jang et al., 2016).
We have previously reported that 24S-HC, a side chain oxidized derivative of cholesterol synthesized by CYP46A1 in neurons, is a potent positive allosteric modulator (PAM) of
NMDARs, a class of glutamate receptors that triggers learningrelated synaptic plasticity (Paul et al., 2013; Sun et al., 2016a,b).
Additionally, we found that 25HC is a partial oxysterol agonist
with weaker PAM activity at NMDARs and is a functional inhibitor of the effects of 24S-HC on NMDARs (Linsenbardt et al.,
2014). In the present study, we examined the effects of a known
proinflammatory stimulus, LPS, on the production of 25HC in
microglia and the effects of LPS and 25HC on long-term potentiation (LTP) in the CA1 region of the rodent hippocampus.
We provide evidence that LPS stimulates enhanced expression of Ch25h and increases 25HC synthesis in microglia,
and that both LPS and 25HC impair synaptic plasticity in
the CA1 hippocampal region. The effects of LPS on hippocampal synaptic plasticity and on a one-trial learning task
in vivo were not observed in Ch25h knock-out (KO) mice,
suggesting that 25HC mediates or contributes to neuroinflammation-impaired learning and memory.

Materials and Methods
Animals. Homozygous Ch25h KO mice (Ch25h KO) backcrossed to
C57BL/6J mice for .10 generations (Bauman et al., 2009) were obtained
from The Jackson Laboratory (stock #016263). C57BL/6J mice (The
Jackson Laboratory) were used as wild-type controls. Sprague Dawley
albino rats were obtained from Harlan Laboratories and were housed in
approved facilities at Washington University in St. Louis. Animal use followed National Institutes of Health guidelines and was approved by the
Washington University in St. Louis Institutional Animal Care and Use
Committee.
Microglia cultures. Primary mouse microglia were prepared from
postnatal day 2 (P2) to P3 pups of both sexes from wild-type and Ch25h
KO mice on a C57BL/6J background (Bohlen et al., 2017). Brains were
dissected into HBSS (catalog #14175–079, Thermo Fisher Scientific).
After removing the olfactory bulb, cerebellum, brainstem, and meninges,
the cortices were transferred to 1 ml of warm TrypLE Express reagent
(catalog #12605–010, Thermo Fisher Scientific) and incubated at 37°C
for 10–20 min for tissue dissociation. Trypsin activity was stopped by
addition of media containing 10% fetal bovine serum, triturated, filtered
through a 100 mm nylon filter and plated in poly-D-lysine-coated T75
flasks in 20 ml culture media [DMEM/F12 containing 10% fetal bovine
serum, GlutaMAX, Na-pyruvate, penicillin/streptomycin, and 5 ng/ml
granulocyte-macrophage colony-stimulating factor (GM-CSF); catalog
#1320–03-5, GOLDBIO]. After cells were confluent, the flasks were
shaken at 200 rpm at 37°C for 30 min. Floating cells were collected,
washed, counted, and plated in culture media without GM-CSF at a density of 106 cells/1000 mm2. Because serum can decrease microglial activation and skew results, we used serum-free media modified from the
study by Bohlen et al. (2017) containing DMEM/F12, 0.1% BSA,
GlutaMAX, penicillin/streptomycin, N-acetyl cysteine and 1 ITS
Media Supplement (catalog #AR013, R&D Systems).
Quantitative PCR. For gene expression studies, microglia were
treated with 100 ng/ml LPS or PBS for 24 h in triplicate. RNA from
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Figure 1. Expression of Ch25h and production of 25HC by microglia in response to LPS
treatment for 24 h. A, Ch25h gene expression was measured by qPCR and normalized to
actin (Actb). Control and LPS values were compared by t tests. B, Conditioned culture media
from PBS vehicle control (Ctrl), LPS-treated wild-type (WT), or Ch25h KO microglia were used
to estimate the amount of 25HC by liquid chromatography-mass spectrometry. Statistical significance was assessed using two-way ANOVA (adjusted p value: *p , 0.05, **p , 0.005,
***p , 0.0005, ****p , 0.0001).
treated microglia was isolated using Qiagen RNeasy Mini Kit. For cDNA
synthesis, a first strand cDNA synthesis kit (igScript; Intact Genomics)
was used. Relative gene expression was measured by quantitative PCR
(qPCR) using PrimeTime Gene Expression Master Mix and Primetime
probe-based assays for mouse Ch25h and Actb (actin) from Integrated
DNA Technologies. Reactions were performed on StepOnePlus RealTime PCR System (Thermo Fisher Scientific). Data analysis was performed using Expression Suite software (Thermo Fisher Scientific).
Oxysterol measurements. Microglia cultures harvested by shaking
mixed glial cultures, as described above, were plated in culture media
without GM-CSF on uncoated plastic. On day 3, cells were washed with
warm PBS and media was replaced with serum-free media with or without 100 ng/ml LPS. Following incubation for 24 h, media was harvested
and centrifuged at 10,000  g for 5 min at room temperature to remove
cell debris. Supernatants were collected in fresh tubes and subjected to
derivatization followed by liquid chromatography-mass spectrometry as
described in the study by Jiang et al. (2007). The amount of 25HC was
estimated based on the peak area of an internal standard of deutrated25-hydroxycholesterol.
Hippocampal slice preparation. Hippocampal slices were prepared
from P28 to P32 male albino rats or mice using previously described
methods (Tokuda et al., 2010, 2011). Dissected hippocampi were pinned
at their ventral pole on a 3.3% agar base in ice-cold artificial CSF (ACSF)
containing the following (in mM): 124 NaCl, 5 KCl, 2 MgSO4, 2 CaCl2,
1.25 NaH2PO4, 22 NaHCO3, and 10 glucose, bubbled with 95% O2-5%
CO2 at 4–6°C. The dorsal two-thirds of the hippocampus was cut into
500 mm (rat) or 400 mm (mouse) slices using a rotary tissue slicer.
Acutely prepared slices were kept in an incubation chamber containing
gassed ACSF for at least 1 h at 30°C before further study.
Hippocampal slice physiology. For electrophysiological studies, slices
were transferred to a submersion-recording chamber at 30°C with ACSF
and perfused continuously at 2 ml/min. Extracellular recordings were
obtained from the apical dendritic layer (stratum radiatum) of the CA1
region for monitoring EPSPs with electrodes filled with 2 M NaCl (5–10
MV resistance).
EPSPs were evoked using 0.1 ms constant current pulses through a
bipolar stimulating electrode in the Schaffer collateral (SC) pathway.
Baseline responses were monitored by applying single stimuli to the
SC pathway every 60 s at half-maximal intensity based on a control
input–output (IO) curve. After obtaining stable baseline recordings for at least 10 min, LTP was induced by a single 100 Hz  1 s
high-frequency stimulation (HFS) using the same intensity stimulus. Following HFS, responses were monitored by single stimuli
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Figure 2. LPS inhibits LTP in the CA1 region of rat hippocampal slices. A, When administered for 10 min just before 100 Hz  1 s HFS, 1 mg/ml LPS (black bar) inhibited the induction of
LTP induced by 100 Hz  1 s HFS (arrow; black circles). Control LTP in naive hippocampal slices is shown in white circles. Traces to the right of this graph and in subsequent figures show representative EPSPs at baseline before HFS (dashed traces) and 60 min following HFS (red traces). B, A low concentration of LPS (10 ng/ml) also inhibits LTP when administered for 1 h before
and during slice recording. Calibration: 1 mV, 5 ms.
once per minute during the period of post-tetanic potentiation
(PTP) and then every 5 min for the remainder of an experiment.
For display purposes, graphs show data every 5 min except during
initial PTP.
Isolated EPSPs mediated by NMDARs were recorded with very lowfrequency SC stimulation (1/min) in ACSF containing 0.1 mM Mg21
and 2.5 mM Ca21, to promote NMDAR activation, and 30 mM CNQX
(6-cyano-7-nitroquinoxaline-2,3-dione), to eliminate the contribution of
AMPARs to evoked EPSPs (Izumi et al., 2005).
Behavioral studies. Wild-type and Ch25h KO mice were tested for
memory acquisition in a one-trial inhibitory avoidance learning task
(Whitlock et al., 2006; Tokuda et al., 2010; Izumi and Zorumski,
2020; Izumi et al., 2021). The testing apparatus consists of two
chambers, one of which is lit and the other is dark; both compartments have a floor of stainless steel rods (4 mm in diameter, spaced
10 mm apart) through which an electrical shock could be delivered
in the dark chamber (12  20  16 cm). The adjoining safe (lit) compartment (30  20  16 cm) was illuminated with four 13 W lights.
Light intensity in the lit chamber was 1000 lux, while that in the
dark chamber was ,10 lux. On the first day of testing, mice were
placed in the lit chamber and allowed to habituate to the apparatus
by freely moving between chambers for 10 min. No footshocks were
given during this pre-exposure trial. On the next day, mice were
administered LPS (1 mg/kg, i.p.) or vehicle (saline) 1 h before training. At the time of training, animals were initially placed in the lit
compartment and allowed to explore the apparatus freely for up to
300 s (5 min). When the mice completely entered the dark chamber,
they were immediately given a footshock. Upon returning to the lit
(safe) chamber, animals were removed from the apparatus and
returned to their home cages. On the next day of testing, mice were
placed in the lit chamber without any drug treatment and the latency to enter the dark compartment was recorded over a 300 s trial.

Chemicals. Deuterated (d6) 25-hydroxycholesterol was purchased
from Avanti Polar Lipids (catalog #700053). The enantiomer of 25HC
was synthesized from Ent-Testosterone, as described previously
(Westover and Covey, 2006; Linsenbardt et al., 2014). Minocycline
and 25HC were from Sigma-Aldrich as was LPS, and phenol was
extracted from Escherichia coli serotype O111:B4 (L2630). IAXO-102
was purchased from AdipoGen Life Sciences, and TAK-242 was purchased from R&D Systems. LPS from Rhodobacter sphaeroides (LPSRS) was purchased from InvivoGen. Other chemicals and salts were
obtained from Millipore Sigma. For microglial depletion experiments,
wild-type mice were fed PLX5622 (Selleck Chemicals) formulated in
chow (AIN-76A) at 1200 ppm (Research Diets) for 7–14 d, beginning
at the time they were weaned, before preparing hippocampal slices.
Drugs were prepared as stock solutions in either ACSF or DMSO and
diluted to final concentration at the time of experiment.
Statistical analysis. Physiologic data were collected and analyzed
using PClamp software (Molecular Devices). Data are expressed as the
mean 6 SEM 60 min following HFS and are normalized with respect to
initial baseline recordings (taken as 100%). In most studies, a two-tailed
Student’s t test was used for comparisons between groups. In cases of
non-normally distributed data, the nonparametric Wilcoxon rank-sum
test was used. For experiments in wild-type and Ch25h KO mice, data
were analyzed by two-way ANOVA followed by Tukey’s multiple-comparison test. Statistical comparisons in physiological studies were based
on IO curves at baseline and 60 min following HFS to determine the
degree of change in EPSP slope at the 50% maximal point, with p , 0.05
considered to be significant. Statistical analyses were performed using
commercial software (SigmaStat, Systat). Data shown in figures for physiological studies are derived from continuous monitoring of EPSPs at
low frequency during the course of experiments and thus may differ
from results described in the text, which represent analyses based on
comparison of input–output curves before and 60 min following HFS.
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microglia produced 6.8-fold higher levels
of 25HC than did Ch25h KO microglia in
the absence of LPS treatment (Fig. 1B; control samples: 1.83 6 0.83 vs 0.27 6 0.042 ng/
ml, respectively).
To determine whether LPS alters hippocampal synaptic function, we examined
effects in ex vivo hippocampal slices from
rats and mice, focusing on studies in P28
to P32 albino rats in the majority of studies, except as otherwise noted. When
administered for 10–30 min at concentrations of 1 and 10 mg/ml before and during
a single 100 Hz  1 s HFS, LPS disrupted
LTP induction without significantly altering baseline synaptic responses [1 mg/ml:
102.4 6 4.2% of baseline EPSP slope measured 60 min following HFS (N = 5) vs
137.4 6 5.6% change in controls (N = 5;
p = 0.0011; Fig. 2A); 10 mg/ml: 88.5 6 5.8%
of baseline 60 min following HFS (N = 5,
p = 0.0003) vs control LTP]. A short (15–
30 min) exposure to a lower concentration
of LPS (100 ng/ml) failed to alter baseline
synaptic responses or LTP [129.9 6 8.0%
of baseline (N = 5, p = 0.4645) vs control
LTP]. However, longer preincubations
with either 10 or 100 ng/ml LPS for 2–3 h
resulted in a profound decrease in the ability of Schaffer collateral synapses to
undergo LTP [10 ng/ml: 96.6 6 5.9% of
baseline EPSP slope measured 60 min following HFS (N = 5; p = 0.0010) vs control
LTP (Fig. 2B); 100 ng/ml: 86.3 6 9.7% of
baseline EPSP slope (N = 6, p = 0.0020)].
The inhibition of LTP by LPS did not
result from the block of NMDARs. At
10 mg/ml, LPS produced a slowly developing, but variable, enhancement rather than
inhibition of NMDAR-mediated synaptic
Figure 3. LPS produces a persistent LTP inhibition that is prevented by an NMDAR antagonist. A, At 10 mg/ml, LPS proresponses (214.2 6 51.5% change; N = 5;
duced a slowly developing increase in NMDAR-mediated EPSPs (black circles). This effect was completely inhibited by the
Fig. 3A). The slowly developing augmentaNMDAR antagonist D-APV (white circles). Traces to the right of the graph show representative NMDAR EPSPs before (dashed
traces) and 10 min following LPS administration (red traces). B, LPS inhibited LTP when administered at 1 mg/ml for 10 min
tion of NMDAR responses was completely
(black bar) and washed out 30 min before HFS (arrow). C, Similar persisting LTP inhibition was observed with 10 mg/ml LPS
blocked by coadministration of the com(black bar, black circles). This prolonged LTP inhibition was completely reversed by coadministration of D-APV (white bar)
petitive NMDAR antagonist, D-2-amino-5during LPS perfusion (white circles); D-APV and LPS were washed out of the slices at the same time. Traces to the right of
phosphonovalerate (D-APV; 101.7 6 4.7%;
the graphs in B and C show representative EPSPs, as in Figure 1. Calibration: 1 mV, 5 ms.
N = 5; Fig. 3A). Variable enhancement
but not inhibition of NMDAR responses
Results
by LPS was also observed at 100 ng/ml
In initial experiments, we examined the effects of LPS on the
(145.2 6 17.2% change 60 min following washout; N = 5).
The augmentation of NMDAR responses by LPS raises the
expression of Ch25h and levels of 25HC in cultured microglia.
possibility that LPS acts as an acute direct or indirect neuroAt a concentration of 100 ng/ml, LPS treatment increased levels
nal stressor to disrupt LTP induction. Previously, we have
of Ch25h to ;30 times that of baseline after 24 h (Fig. 1A). As
expected, microglia from Ch25h-deficient (Ch25h KO) mice had
observed that several forms of neuronal stress result in
no expression of enzyme (data not shown). Consistent with
untimely NMDAR activation to inhibit LTP induction via a
enzyme expression data, levels of 25HC were increased by
form of negative metaplasticity (Zorumski and Izumi,
2012). In these cases, even brief applications of such stres.200% in conditioned media of LPS-treated wild-type microglia
sors can disrupt LTP for a prolonged period following recompared with that of control (PBS)-treated microglia over the
moval of the stressor, and this form of LTP inhibition can
same period of time (Fig. 1B). On the other hand, conditioned
be prevented by the NMDAR antagonist D-APV when coapmedia from Ch25h-deficient microglial cultures only showed
very low levels of 25HC with no enhancement in the presence of
plied with the stressor. Similar to these prior observations,
LPS (Fig. 1B), indicating that Ch25h is the prime mediator of
we found that the administration of 1 or 10 mg/ml LPS for
25HC synthesis in these cells. We also note that wild-type
10 min, with LPS washout 30 min before HFS, prevented
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LTP induction [100.5 6 3.4% of baseline
with 1 mg/ml LPS (N = 5, p = 0.0005) vs control LTP; Fig. 3B]. Consistent with an NMDARmediated metaplastic mechanism, this persisting
form of LTP inhibition by LPS was blocked
by cotreatment with APV during the period of
LPS administration (10 mg/ml LPS, 91.2 6 6.3%;
vs LPS 1 APV, 133.9 6 6.8%; N = 5 each; p =
0.0018; Fig. 3C).
To determine whether microglial activation
contributes to the effects of LPS, a known
proinflammatory stimulus, on LTP, we used
minocycline, an anti-inflammatory agent that
inhibits microglial-mediated inflammatory
activation (Tikka and Koistinaho, 2001; Wu
et al., 2015). In the presence of 0.5 mM minocycline, 1 mg/ml LPS failed to block LTP
[142.3 6 10.5% (N = 5, p = 0.0053) vs LPS
alone; Fig. 4A]. We also attempted to deplete
microglia by feeding mice PLX5622, a colony-stimulating factor 1 receptor antagonist,
for 7–14 d postweaning (Henry et al., 2020;
Liu et al., 2021). LTP induction remained
intact in mice fed a control diet (AIN-76A),
and 1 mg/ml LPS inhibited LTP in slices from
these mice [control LTP, 161.6 6 13.0%
(N = 4) vs LPS-treated slices, 93.6 6 5.4%
(N = 4; p = 0.0029)]. LTP, however, could not
be induced in mice fed PLX5622 [101.6 6
7.7% (N = 4; p = 0.0075) vs LTP in control
mice].
Prior studies indicate that LPS can act on
microglia through cell surface receptor and intracellular mechanisms, including activation
of Toll-like receptor 4 (TLR4; Gaikwad and
Agrawal-Rajput, 2015). To probe these potential mechanisms, we initially examined the
effects of LPS-RS, an LPS derivative that antagonizes both TLR4-dependent and TLR4-independent effects of LPS in microglia and other
cells (Kutuzova et al., 2001; Gaikwad and
Agrawal-Rajput, 2015). When slices were pretreated with 3 mg/ml LPS-RS for 15 min before
and during 15 min LPS exposure, we found
that LPS no longer inhibited CA1 LTP acutely
[173.1 6 5.9% (N = 5; p = 0.0015) vs LPS alone; Figure 4. Minocycline and LPS-RS, but not selective TLR4 antagonists, overcome the effects of LPS on LTP. A, At
Fig. 4B]. When administered alone, LPS-RS 0.5 mM, the microglial inhibitor, minocycline (white bar) overcomes the persistent effects of LPS (black bar) on LTP. B,
had no significant effect on LTP compared At 3 mg/ml, the LPS antagonist LPS-RS prevented the acute effects of 1 mg/ml LPS on LTP (black circles).
with naive controls [157.6 6 11.3% (N = 5; Administration of LPS-RS alone did not affect LTP (white circles). C, D, In contrast to LPS-RS, two selective TLR4 antagp = 0.1479) vs control LTP; Fig. 4B]. Because onists (IAXO and Tak 242) failed to alter the ability of 1 mg/ml LPS (black bars) to inhibit LTP. Traces show representaLPS can activate TLR4, we also examined the tive EPSPs. Calibration: 1 mV, 5 ms.
effects of two selective TLR4 antagonists,
on Ch25h and 25HC observed in biochemical studies (Fig. 1) are
IAXO-102 (Huggins et al., 2015) and TAK-242
related to LPS-induced changes in LTP. In slices from both wild(Matsunaga et al., 2011); neither of these TLR4 antagonists
type and Ch25h KO mice, LTP was readily induced [wild type:
altered LTP inhibition by LPS. At a concentration of 5 mM,
144.8 6 7.4% of baseline (N = 5; Fig. 5A, white circles); KO:
IAXO-102 did not acutely alter the effects of LPS [109.4 6 4.6%
151.8 6 13.8% change 60 min after HFS (N = 5; Fig. 5A, white
(N = 5, p = 0.2937) vs LPS alone; Fig. 4C]. Similarly, TAK-242 (1
squares; p = 0.9571)]. In wild-type mice, LPS readily inhibited
mM) failed to alter LTP block by LPS [107.3 6 5.2% (N = 5,
LTP induction (97.9 6 4.9% vs control LTP; N = 5; p = 0.0240;
p = 0.4844) vs LPS alone; Fig. 4D]. A longer administration of
Fig. 5B, black circles). Even in the presence of LPS, HFS induced
TAK-242 (1 h total) also failed to overcome LPS (97.2 6 5.8%
robust LTP in slices from KO mice [140.4 6 5.7% (p = 0.9883) vs
change; N = 4).
control LTP in wild-type mice; Fig. 5B, black squares; overall
Using hippocampal slices prepared from Ch25h KO mice
(Bauman et al., 2009), we examined whether the effects of LPS
two-way ANOVA, p = 0.0088 for these four groups]. We also
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exposure [158.3 6 20.4% (N = 5, p = 0.014)
vs 10 mM 25HC; Fig. 6D].
Because our results suggest that 25HC
likely acts downstream of microglia activation
by LPS, we examined whether minocycline
altered the effects of 25HC on LTP. In contrast to LPS, we found that minocycline failed
to block the inhibition of LTP by 10 mM
25HC (99.6 6 6.5%, N = 5; Fig. 7A). Also in
contrast to LPS (Fig. 5), we found that 10 mM
25HC acutely inhibited LTP in slices from
Ch25h-deficient mice [104.1 6 5.4% (N = 7;
p = 0.0041) vs control LTP in Ch25h KO
mice; Fig. 7B]. Because 25HC appears to act
as a weak partial agonist and functional noncompetitive antagonist at a putative oxysterol
site on NMDARs (Paul et al., 2013;
Linsenbardt et al., 2014), we also examined
whether the effects of 25HC on LTP are
altered in hippocampal slices from mice deficient in CYP46A1, the enzyme responsible
for synthesis of 24S-HC (Russell et al., 2009),
a full agonist positive allosteric modulator of
NMDARs (Linsenbardt et al., 2014). In slices
from CYP46A1 knock-out mice (Lund et al.,
2003) that we previously showed has intact
LTP (Sun et al., 2016a), we found that LTP
was not induced in the presence of 10 mM
25HC (103.8 6 7.0%; N = 4; Fig. 7C).
To determine whether 25HC contributes
to in vivo effects of LPS, we examined the
ability of LPS to alter LTP when administered
systemically to wild-type and Ch25h KO
Figure 5. LPS inhibits LTP in slices from wild-type mice but not Ch25h KO mice. A, Both wild-type (white circles) and
mice. For these experiments, mice were
Ch25h KO (white squares) slices exhibit robust LTP under baseline conditions. B, LPS (black bar) inhibits LTP in slices
from wild-type slices (black circles) but not Ch25h KO slices (black squares). C, In slices from wild-type mice, 10 mg/ml
treated with 1 mg/kg (i.p.) LPS at times rangLPS  15 min augmented NMDAR-mediated EPSPs (black circles); in KO slices, LPS had no effect (black squares). Traces
ing from 1 to 24 h before hippocampal slice
to the right of the graphs show representative EPSPs at baseline (dashed traces) and 60 min following HFS or LPS (red
preparation. In slices from wild-type mice, in
traces). Calibration: 1 mV, 5 ms.
vivo LPS completely inhibited LTP at all times
.1 h after injection (24 h after LPS injection
found that the ability of 10 mg/ml LPS to augment NMDARwild-type mice exhibited EPSPs that were
mediated EPSPs was eliminated in slices from Ch25h KO mice
102.4 6 4.5% of baseline 60 min following HFS, N = 6; Fig. 8A,
[wild type, 128.6 6 7.7% of baseline (N = 5) vs KO, 93.6 6 3.1%
white circles). In contrast, LPS treatment had no effect on LTP in
(N = 6; p = 0.0015; Fig. 5C)].
slices from Ch25h KO mice [141.0 6 11.9% of baseline (N = 6,
The results outlined above indicate that LPS-mediated LTP
p = 0.0126) vs LPS in wild-type mice; Fig. 8A, white squares].
inhibition is likely mediated by 25HC. These observations
We also examined whether the effects of LPS on LTP are
prompted us to examine whether exogenously administered
associated with impaired learning in wild-type and Ch25h KO
25HC mimics the effects of LPS on LTP and NMDAR-medimice. For these experiments, we examined learning acquisition
ated EPSPs in rat hippocampal slices. Similar to LPS, pretreatand retention in mice treated with LPS 1 h before testing in a
ment of hippocampal slices with 10 mM 25HC for 15 min just
one-trial inhibitory avoidance learning task. In this task, mice are
before HFS completely inhibited LTP [97.7 6 5.7% of baseinitially placed in the lit compartment of a testing chamber that
line 60 min following HFS (N = 5, p = 0.0011) vs control LTP;
has illuminated and dark chambers. During the training phase,
Fig. 6A]. The effect of 25HC on LTP was not mimicked by its
once mice enter the dark compartment, they are given a footunnatural enantiomer (10 mM), indicating structural selectivshock and removed from the apparatus. When tested 24 h later,
ity for the inhibition of LTP [154.3 6 9.3% (N = 6, p = 0.0008)
mice are again placed in the lit compartment and allowed to
vs natural 25HC; Fig. 6A]. Even at 10 mM, 25HC did not inexplore the device for up to 300 s, receiving no further shocks.
hibit isolated NMDAR responses but rather produced a
Wild-type mice readily learn this task and remain in the lit comsmall, but variable, enhancement (128.7 6 16.1%; N = 9; Fig.
partment for 279.2 6 20.8 s (N = 6) before being removed to their
6B; Linsenbardt et al., 2014). Similar to LPS, 1 or 10 mM
home cage (Fig. 8B). Wild-type mice treated with LPS 1 h before
25HC administered for 10 min and then washed out 30 min
initial exposure to the footshock show impaired learning 24 h
later (remaining in the lit compartment for 132.0 6 42.9 s; N = 9;
before HFS resulted in a persisting block of LTP [1 mM,
90.9 6 7.6% (N = 5, Fig. 6C); 10 mM, 89.0 6 6.6% (N = 5, Fig.
Fig. 8B). Control Ch25h KO mice are indistinguishable from
6D)]. As with LPS, this prolonged LTP inhibition was comwild-type mice under baseline conditions and spent 290.3 6 6.3 s
pletely reversed by coapplication of APV during 25HC
(N = 6) in the lit compartment on testing 24 h after footshock

10060 • J. Neurosci., December 8, 2021 • 41(49):10054–10064

(Fig. 8B). In contrast to wild-type mice,
Ch25h KO mice treated with LPS also
readily learn the task and remained in
the lit compartment for 269.3 6 28.3 s
24 h after exposure to the footshock
(N = 6, Fig. 8B; p = 0.0075 by two-way
ANOVA). There is a significant difference between saline-treated control wildtype mice and LPS-treated wild-type
mice (p = 0.0213; Fig. 8B). No difference
was observed between LPS-treated KO
mice versus saline-treated KO mice
(p = 0.8312), but there is a significant
difference between LPS-treated wildtype mice versus LPS-treated KO mice
(p = 0.0455).
Notably, both wild-type and KO mice
exhibit altered behavior with hypoactivity and weight loss 24 h after LPS [wildtype mice, 3.56 6 0.23 g (N = 9); KO
mice, 2.15 6 0.40 g (N = 6); Fig. 8C],
most likely because of the systemic effects
of LPS. In contrast, both wild-type and
KO control mice not exposed to LPS
show some weight gain 24 h after testing
[wild-type mice, 0.68 6 0.21 g (N = 6);
KO mice, 0.80 6 0.18 g (N = 6; p ,
0.00001 by two-way ANOVA); Fig. 8C].
There is a significant difference between
saline-treated control wild-type mice and
LPS-treated wild-type mice in weight
change (p , 0.0001; Fig. 8C). Similarly,
there is a significant difference between
saline-treated KO mice and LPS-treated
KO mice (p , 0.0001). There is also a significant difference between LPS-treated
wild-type mice and LPS-treated KO mice
(p = 0.0201). Because of the differences
in activity and weight observed 24 h
after treatment with LPS, we tested
learning at shorter intervals following
LPS treatment, as described above, to
minimize potential confounds from
sickness-related behaviors.

Discussion
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Figure 6. Exogenous 25HC mimics effects of LPS on LTP. A, Administration of 10 mM 25HC for 15 min (black bar) before HFS
(arrow) results in LTP inhibition (black circles). At an equimolar concentration, the unnatural enantiomer of 25HC did not alter
LTP induction (white bar and circles). B, 25HC does not inhibit NMDAR-mediated EPSPs and results in a small but variable
enhancement of these responses. C, Akin to LPS, the administration of 25HC (1 mM) for 10 min (black bar) followed by a
30 min washout before HFS (arrow) also results in LTP inhibition. D, Similar persistent LTP inhibition was observed with 10 mM
25HC (black bar, black circles), and this LTP block was overcome by treatment with the NMDAR antagonist, D-APV (white bar,
white circles). Traces to the right of the graph show representative EPSPs, as in other figures. Calibration: 1 mV, 5 ms.

The present results demonstrate that
microglial activation by LPS, a known
proinflammatory stimulus, markedly
increases the expression of Ch25h and
the synthesis of 25HC, and that LPS
and 25HC disrupt hippocampal LTP
via NMDAR-mediated metaplasticity. Thus, LPS-induced
microglial activation adds to neuronal and synaptic stressors
that impair LTP via metaplastic mechanisms (Zorumski and
Izumi, 2012). Other stressors include metabolic challenges
(low glucose) and agents associated with neural toxicity, including ethanol and corticosterone (Zorumski and Izumi, 2012;
Zorumski et al., 2014). In all of these examples, the administration of the NMDAR antagonist APV during the stress prevents
persisting adverse effects on LTP. Whether microglial activation
and 25HC contribute to the effects of other stressors remains to

be determined, although these various stressors are known
to disrupt learning and memory (Zorumski and Izumi, 2012).
Prior studies have shown that LPS can disrupt LTP when
administered in vivo or in ex vivo slices (Nolan et al., 2004;
Maggio et al., 2013; Bie et al., 2014). In some cases, LPS increases
neuronal excitability (Pascual et al., 2012; Gao et al., 2014) and
synthesis of glucocorticoids (Maggio et al., 2013). We previously
reported that corticosterone promotes NMDAR-dependent LTP
inhibition (Izumi et al., 2015). LPS also promotes aerobic glycolysis in microglia via TLR4, resulting in the release of interleukin1 b (IL-1b ) and LTP inhibition (York et al., 2021). Additionally,
LPS promotes hippocampal long-term depression (LTD) when
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100 ng/ml LPS inhibited LTP when
administered for 2–3 h (Fig. 2), and the
effects on LTP were mimicked by shorter
duration exposures to higher concentrations. Additionally, wild-type microglia
have higher baseline levels of 25HC compared with Ch25h KO microglia, and these
differences may contribute to effects seen
with shorter applications of LPS. Our
experiments do not distinguish whether
short exposures to LPS promote the
release of basal 25HC or newly synthesized
oxysterol, but we note that prior studies
observed changes in hippocampal excitability with shorter duration exposures
(5–30 min), including rapid production
and release of neuromodulators (Pascual
et al., 2012; Gao et al., 2014; Tzour et al.,
2017).
In our study, microglial activation by
LPS appears independent of TLR4, a pattern recognition receptor activated by
LPS, although LPS also stimulates CR3
(Zhang et al., 2014a) and can have direct
intracellular effects via noncanonical
inflammasome activation (Shi et al., 2014).
Inhibition of the effects of LPS on LTP by
LPS-RS, but not more selective TLR4
inhibitors, is consistent with the known
direct effects of LPS-RS on LPS internalization and caspase-11 (Kutuzova et al.,
2001; Shi et al., 2014). However, LPS-RS
also inhibits TLR4 (Coats et al., 2005;
Gaikwad and Agrawal-Rajput, 2015),
making it likely that multiple mechanisms
contribute to the effects we observed.
Figure 7. Minocycline does not alter the effects of 25HC on LTP and 25HC inhibits LTP in slices from Ch25h and CYP46A1
We also note that certain effects of LPS on
KO mice. A, Unlike LPS, minocycline (white bar) failed to alter persistent LTP inhibition by 25HC (black bar). B, C, 25HC inhibhippocampal plasticity in other studies
ited LTP in slices from Ch25h KO mice (B) and CYP46A1 KO mice (C). Traces to the right of the graphs show representative
were independent of TLR4 (Zhang et al.,
EPSPSs, as in prior figures. Calibration: 1 mV, 5 ms.
2014a). Our results differ from observations in cultured mouse bone marrowadministered in combination with a metabolic stressor through a
derived macrophages where LPS markedly
mechanism that involves complement receptor 3 (CR3), but
stimulates Ch25h expression in wild-type cells but not TLR4-denot TLR4 (Zhang et al., 2014a). Similarly, we found that the
ficient cells (Diczfalusy et al., 2009). Differences in cell types and
induction of LTD by low-frequency synaptic stimulation
tissue preparation may account for differences we observed using
produces metaplastic LTP inhibition (Izumi et al., 2013). The
selective TLR4 antagonists, although significant increases in
ability of LPS to enhance hippocampal excitability (Pascual
Ch25h expression were observed in macrophages by 2 h (the
et al., 2012; Gao et al., 2014) is consistent with effects on LTP
shortest time studied), consistent with the time course of LTP invia NMDAR activation, shown here. However, LPS produced
hibition that we observed with LPS (in nanograms per milliliter)
no change in AMPAR EPSPs when administered before LTP
in hippocampal slices.
induction, suggesting that the increase in NMDAR EPSPs is
Effects of LPS on LTP are mimicked by exogenously adminislikely postsynaptic in origin. LPS may also disrupt LTP via
tered 25HC in both wild-type and Ch25h-deficient mice, indicatMAPK activation (Nolan et al., 2004), and we have found
ing structural sterol selectivity. These results are consistent with
that p38 MAPK contributes to metaplastic LTP inhibition
studies in peripheral inflammatory cells where 25HC is the major
(Izumi et al., 2008). Whether LPS activates other modulators
endogenous oxysterol synthesized and released from macroinvolved in metaplastic LTP inhibition, including nitric oxide
phages (Blanc et al., 2013). The Brain RNA-Seq database suggests
(Izumi et al., 1992) and the neurosteroid allopregnanolone
that mouse Ch25h as well as human CH25H are expressed
(Tokuda et al., 2011), requires further study.
largely, if not exclusively, in microglia (Zhang et al., 2014b). In
Our results indicate that microglial activation by LPS prothe periphery, 25HC has complex effects on inflammatory
motes synthesis of the endogenous oxysterol 25HC and that
responses and has been described as a “context-dependent”
genetic deletion of Ch25h abrogates LPS-induced LTP inhibition.
modulator (Fessler, 2016) with both positive and negative effects
Our biochemical studies were based on 24 h incubations in a low
on inflammatory responses (Gold et al., 2014; Reboldi et al.,
concentration of LPS (e.g., 10 ng/ml). We also found that 10–
2014; Jang et al., 2016; Mutemberezi et al., 2018). Recent studies
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in microglia indicate that LPS promotes the
production of proinflammatory cytokines IL1 b and IL-1a, and these effects are dampened
in Ch25h-KO animals (Wong et al., 2020). In
contrast, LPS-stimulated production of TNFa
and IL-6 is not altered in these knock-out mice
(Wong et al., 2020). The ability of 25HC to promote LPS-stimulated IL-1b induction in
microglia is also enantioselective, consistent
with what we observed in our LTP experiments
(Wong et al., 2020).
25HC has several actions that could contribute to LTP inhibition. We previously found
that 25HC is a partial agonist at a putative oxysterol site on NMDARs, with weak ability to
enhance NMDAR responses while dampening
the effect of more effective agonists such as
24S-HC (Linsenbardt et al., 2014). Effects
against oxysterol NMDAR PAMs is noncompetitive and enantioselective (Linsenbardt et
al., 2014). Here we found that effects of 25HC
against LTP are not mimicked by ent-25HC at
an equimolar concentration. Inhibitory effects
of 25HC on 24S-HC appear unlikely to contribute to effects on LTP because 25HC dampens LTP in slices from CYP46A1-deficient
mice that do not produce significant amounts
of 24S-HC (Sun et al., 2016a), and we previously found that 24S-HC promotes rather than
inhibits LTP (Paul et al., 2013; Izumi et al.,
2021). In contrast, 25HC regulates cellular cholesterol homeostasis, although these effects are
nonenantioselective in contrast to what we
have observed with LTP (Olsen et al., 2012).
25HC also activates the integrated stress Figure 8. Effects of LPS in vivo. A, Administration of LPS (1 mg/kg, i.p.) 1 h before hippocampal slice preparation
response (ISR) via GCN2 kinase (Shibata et al., results in a defect in LTP induction in wild-type mice (white circles). In contrast, similar administration of LPS in Ch25h
2013). Activation of ISR as a mechanism to in- KO mice does not alter LTP (white squares). Traces to the right of the graph show representative EPSPs. Calibration:
hibit LTP is consistent with the ability of 1 mV, 5 ms. B, In wild-type mice, LPS administered 1 h before inhibitory avoidance training results in a defect in learnISRIB, a small-molecule ISR inhibitor, to pro- ing as manifested by mice more readily leaving the lit chamber to enter the dark chamber where they had received a
mote synaptic plasticity and learning in other footshock 24 h previously. In contrast, LPS had no effect on learning in Ch25h KO mice. C, LPS resulted in weight loss
studies (Sidrauski et al., 2013; Di Prisco et al., 24 h following administration in both wild-type and KO mice, although the amount of weight loss was less in the KO
2014; Chou et al., 2017), including the ability to mice. *p , 0.05; ****p , 0.0001 by two-way ANOVA.
overcome metaplastic LTP inhibition by
NMDA and ethanol (Izumi and Zorumski,
Neuropsychiatric illnesses are major causes of death and dis2020). Activation of endoplasmic reticulum
ability, and major depression is a leading cause of disability
(ER) cellular stress responses also promotes the movement of
worldwide. Importantly, neuroinflammatory changes in brain
cholesterol from ER to mitochondria, resulting in the production
are thought to contribute significantly to the pathophysiology
of pregnenolone (Barbero-Camps et al., 2014), the first step in
of these illnesses and represent potentially novel targets for
the synthesis of neurosteroids such as allopregnanolone, a modutherapeutic interventions (Kiecolt-Glaser et al., 2015; Yirmiya
lator involved in metaplastic LTP inhibition (Tokuda et al.,
et al., 2015). While neuroinflammation contributes to multiple
2011). 25HC also has complex effects on inflammasomes and
facets of neuropsychiatric disorders including illness-related
can promote the release of inflammatory cytokines such as interbehaviors (pain, sleep, and appetite changes), the effects of
leukin-1 b that can have adverse effects on synaptic function
inflammation on synaptic function may be a major contribu(Gold et al., 2014; Jang et al., 2016; Wong et al., 2020). While we
tor to illness-related disability. The results presented here
did not examine intracellular mechanisms contributing to the
indicate that 25HC is an important endogenous modulator
effects of LPS or 25HC, we have previously found that NMDARthat can be released from microglia to mediate the effects of
mediated LTP inhibition, akin to what we observed here, involves
an inflammatory stimulus on hippocampal network function
complex signaling including phosphatases, nitric oxide synthase,
and learning. Hence, these studies provide a potential avenue
and p38 MAPK (Zorumski and Izumi, 2012). It will be important
for novel treatments for cognitive dysfunction in a range of
to pursue these cellular mechanisms in future studies, including
disorders, and thus represent potential strategies to reduce
the effects of LPS and 25HC on both NMDAR function and LTP.
societal impact and devastating consequences of certain neuNonetheless, 25HC appears to be a key mediator of the effects of
ropsychiatric illnesses, including perhaps longer-term sequeLPS based on observations in Ch25h-deficient slices, likely in part
via direct effects on NMDARs (Linsenbardt et al., 2014).
lae of COVID-19 (Wang et al., 2020).
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